Global health solutions firm Zuellig Pharma has teamed up with the Plastic Credit Exchange (PCX) to reduce its production of plastic packaging waste pursuant to the Extended Producers Responsibility Act of 2022 or EPR Law, which states that 80 percent of plastic waste must be recovered and diverted by 2028.
PCX is a Producers Responsibility Organization (PRO) that engages with business enterprises on ways to reduce their plastic footprint such as plastic reduction, reusing, recycling, offsetting, and enabling the circular economy.
By signing the agreement, Zuellig Pharma has been included in the PCX's membership roster for companies that have committed compliance to the EPR Law and will report to the Department of Environment and Natural Resources (DENR).
PCX will be able to help the company register its plastic packaging footprint, and implement recovery and diversion programs, as well as plastic offsetting services.
Zuellig Pharma said that it will coordinate with its clients in the pharmaceutical and medical sectors to adhere to the EPR Law.
“The partnership with PCX is important for us, as we work towards reducing our impact on the environment across our operations and supply chains, specifically with plastic waste,” said Zuellig Pharma Philippines Market Managing Director Jannette Jakosalem.
“This is part of our commitment to build a healthier and more sustainable future in the country and for all in Asia,” she added.
Recently, Zuellig Pharma also inked a power supply agreement with ACEN's retail electricity arm Renewable Energy (RE) Solutions to supply 100 percent RE for Zuellig Pharma's Santa Rosa Distribution Center and Canlubang Distribution Center, which is estimated to reduce 10,600 tons of carbon emissions annually.